The case against COVID-19 vaccine mandates in pediatric solid organ transplantation

Lainie Friedman Ross1,2,3, Douglas J Opel4,5

  • 1Department of Pediatrics, University of Chicago, Chicago, IL, USA.

Pediatric Transplantation
|February 12, 2022
PubMed

Insights

Mandating COVID-19 vaccination for pediatric solid organ transplant (SOT) candidates and their households is not ethically justifiable. The potential harm of denying transplantation outweighs the risks associated with remaining unvaccinated.

Area of Science:

  • Pediatric Ethics
  • Transplant Medicine
  • Infectious Disease Control

Background:

  • Joint statements recommend COVID-19 vaccination for solid organ transplant (SOT) recipients and close contacts.
  • Some SOT programs mandate vaccination for listing and transplantation.

Purpose of the Study:

  • To ethically evaluate the justification for mandating COVID-19 vaccination in pediatric SOT candidates.
  • To assess the ethical implications of vaccine mandates for SOT candidates, their support persons, and households.

Main Methods:

  • Utilized current best evidence and moral theory.
  • Examined ethical justifications for vaccine mandates in pediatric populations.
  • Applied principles to the SOT context, considering disease prevention and resource stewardship.

Main Results:

  • Vaccine mandates are justifiable for serious vaccine-preventable diseases with high transmission and no less intrusive alternatives.
  • Stewardship of scarce transplant resources can justify mandates if graft loss is a significant risk.
  • Current evidence does not support these criteria for pediatric SOT and COVID-19 vaccination.

Conclusions:

  • Contingent listing on COVID-19 vaccination for pediatric SOT candidates is ethically problematic.
  • The risk of harm from not being listed for transplantation outweighs the risks of remaining unvaccinated.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
69
Vaccinations01:51

Vaccinations

Overview
45.6K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
551
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
16
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
8
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
9